Opposition to vaccination a transatlantic discussion /

Hae kokoteksti

Prescribing medications to children a GP's view /

Hae kokoteksti

Towards developing a universal influenza vaccine

Hae kokoteksti

Monkeypox etiopathogenesis, prevention, and treatments /

Hae kokoteksti
Series

Comparison of immune resilience induced by vaccination versus COVID recovery

Hae kokoteksti
Series

mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals

Hae kokoteksti
Series

SARS-CoV-2 variants implications for immunity and vaccine development /

Hae kokoteksti
Series

Emergence of blood clotting disorders resulting from COVID vaccines inoculations

Hae kokoteksti
Series

SARS-CoV-2 evolution within and between individuals

Hae kokoteksti
Series

The immune system response to the SARS-CoV-2 virus March 2021 update /

Hae kokoteksti
Series

SARS-CoV-2 vaccine rollout campaigns

Hae kokoteksti
Series

SARS-CoV-2 mutations phenotypes and implications for vaccine development /

Hae kokoteksti
Series

The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /

Hae kokoteksti
Series

Imperial College London's saRNA Vaccine - COVAC1

Hae kokoteksti
Series

Human challenge trials for vaccines against COVID-19

Hae kokoteksti
Series

The development of SARS-CoV-2 vaccines

Hae kokoteksti
Series

Nanotechnologies in the fight against coronaviruses

Hae kokoteksti
Series

Development of an intranasal vaccine for SARS-CoV-2

Hae kokoteksti
Series

COVID-19 epidemiology and potential treatments follow up interview /

Hae kokoteksti
Series

Elite controllers of HIV from discovery to future therapies /

Hae kokoteksti
Series